Sometime back I had written a blog about China and south east Asia been favored by Big Pharma for their Research and Development destination and some big pharma’s like Novartis and Novo Nordisk investing heavily on their research collaboration in China and 3M investment in Singapore, Last week some reports stated that Merck Serono (Subsidiary of Merck KgA) is planning to invest Euro 130 Million for its research efforts in China and Roche has already started establishing its research center in Singapore, If we compare Pharma direct investment of China, Singapore and India, we stand no where? What shall be our next step to make India the next Biotech destination?
No comments:
Post a Comment